Literature DB >> 19892919

PDK1 regulates chemotaxis in human neutrophils.

M Yagi1, A Kantarci, T Iwata, K Omori, S Ayilavarapu, K Ito, H Hasturk, T E Van Dyke.   

Abstract

Phosphoinositide-dependent kinase (PDK1) plays a central role in signal transduction mediated by phosphatidylinositol 3-kinases (PI3K) and regulates cellular functions in neutrophils. Neutrophils from individuals diagnosed with localized aggressive periodontitis (LAP) present an in vivo phenotype with depressed chemotaxis. The aim of this study was to test the hypothesis that PDK1 regulates chemotaxis in neutrophils and is responsible for the abnormal neutrophil chemotaxis LAP. Neutrophil chemotaxis was significantly suppressed by the PDK1 inhibitor staurosporine. When cells were transfected with PDK1 siRNA, there was a significant reduction in chemotaxis, while superoxide generation was not significantly affected. In primary neutrophils from persons with LAP, PDK1 expression and activation levels were significantly reduced, and this reduction was associated with the reduced phosphorylation of Akt (Thr308) and chemotaxis. Analysis of these data demonstrates that PDK1 is essential for the chemotactic migration of neutrophils, and in the absence of PDK1, neutrophil chemotaxis is impaired.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892919      PMCID: PMC3144049          DOI: 10.1177/0022034509349402

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  36 in total

Review 1.  Development of a classification system for periodontal diseases and conditions.

Authors:  G C Armitage
Journal:  Ann Periodontol       Date:  1999-12

2.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

Authors:  T Sasaki; J Irie-Sasaki; R G Jones; A J Oliveira-dos-Santos; W L Stanford; B Bolon; A Wakeham; A Itie; D Bouchard; I Kozieradzki; N Joza; T W Mak; P S Ohashi; A Suzuki; J M Penninger
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

3.  Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils.

Authors:  J R Kalmar; R R Arnold; M L Warbington; M K Gardner
Journal:  J Immunol Methods       Date:  1988-06-13       Impact factor: 2.303

4.  Defective chemotaxis and calcium response in localized juvenile periodontitis neutrophils.

Authors:  M A Daniel; G McDonald; S Offenbacher; T E Van Dyke
Journal:  J Periodontol       Date:  1993-07       Impact factor: 6.993

Review 5.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

Authors:  M Baggiolini; B Dewald; B Moser
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

6.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

Review 7.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

8.  Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.

Authors:  M Pouliot; C B Clish; N A Petasis; T E Van Dyke; C N Serhan
Journal:  Biochemistry       Date:  2000-04-25       Impact factor: 3.162

9.  Altered diacylglycerol level and metabolism in neutrophils from patients with localized juvenile periodontitis.

Authors:  S R Tyagi; D J Uhlinger; J D Lambeth; C Champagne; T E Van Dyke
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

10.  Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis.

Authors:  H D Perez; E Kelly; F Elfman; G Armitage; J Winkler
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more
  8 in total

1.  Impaired immune tolerance to Porphyromonas gingivalis lipopolysaccharide promotes neutrophil migration and decreased apoptosis.

Authors:  Svetislav Zaric; Charles Shelburne; Richard Darveau; Derek J Quinn; Sinéad Weldon; Clifford C Taggart; Wilson A Coulter
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

Review 2.  Moving towards a paradigm: common mechanisms of chemotactic signaling in Dictyostelium and mammalian leukocytes.

Authors:  Yulia Artemenko; Thomas J Lampert; Peter N Devreotes
Journal:  Cell Mol Life Sci       Date:  2014-05-21       Impact factor: 9.261

3.  Impaired neutrophil directional chemotactic accuracy in chronic periodontitis patients.

Authors:  Helen M Roberts; Martin R Ling; Robert Insall; Gabriela Kalna; Julia Spengler; Melissa M Grant; Iain L C Chapple
Journal:  J Clin Periodontol       Date:  2015-01-08       Impact factor: 8.728

4.  Hemoadsorption corrects hyperresistinemia and restores anti-bacterial neutrophil function.

Authors:  Anthony Bonavia; Lauren Miller; John A Kellum; Kai Singbartl
Journal:  Intensive Care Med Exp       Date:  2017-08-04

5.  Dual TORCs driven and B56 orchestrated signaling network guides eukaryotic cell migration.

Authors:  Lou W Kim
Journal:  BMB Rep       Date:  2017-09       Impact factor: 4.778

6.  Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway.

Authors:  Brian P Ziemba; John E Burke; Glenn Masson; Roger L Williams; Joseph J Falke
Journal:  Biophys J       Date:  2016-04-26       Impact factor: 4.033

7.  PDK1-mediated activation of MRCKα regulates directional cell migration and lamellipodia retraction.

Authors:  Paolo Armando Gagliardi; Laura di Blasio; Alberto Puliafito; Giorgio Seano; Roberto Sessa; Federica Chianale; Thomas Leung; Federico Bussolino; Luca Primo
Journal:  J Cell Biol       Date:  2014-08-04       Impact factor: 10.539

8.  Transcriptomics of type 2 diabetic and healthy human neutrophils.

Authors:  Sarah E Kleinstein; Jamison McCorrison; Alaa Ahmed; Hatice Hasturk; Thomas E Van Dyke; Marcelo Freire
Journal:  BMC Immunol       Date:  2021-06-16       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.